LUCD
Lucid Diagnostics Inc.
$0.9580
-0.93%
$194.6M
No data for this timeframe.
Vol
Market Cap$194.6M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (91%)
Inst. Holders7 funds
Inst. Value$7.8M
Inst. Activity5 buys / 0 sells
Insider Activity1B / 0S
Insider Net $$245.3K
SEC Reports3
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0001799011·Prev Close $0.9670
Recent Activity
Jun 9, 2026
short_volume
Short Volume: LUCD — 59.8% short (0.3M / 0.5M)
Short: 321,716 | Exempt: 222 | TRF Vol: 538,080 | Short Ratio: 59.8% | Off-exchange volume (dark poo
May 20, 2026
Insider
Matheis Dennis bought 245,000 shares
Director @ $1.00 ($245.3K)
May 14, 2026
SEC
Lucid Diagnostics reported Q1 2026 revenue of $1.3M (up 52% YoY from $0.8M) and a GAAP net loss of $0.17/share, which is
8-K — Impact 5/10
Apr 24, 2026
SEC
Lucid Diagnostics Inc. (LUCD) closed an underwritten public offering of 18 million shares at $1.00 per share, raising $1
8-K — Impact 5/10
Apr 23, 2026
SEC
Lucid Diagnostics is conducting an underwritten public offering of 18 million shares of common stock at a public offerin
8-K — Impact 5/10
Feb 20, 2026
Insider
Matheis Dennis sold 123,000 shares
Director @ $0.00 ($0.00)
Feb 20, 2026
Insider
White Debra sold 123,000 shares
Director @ $0.00 ($0.00)
Inst.
WELLS FARGO & COMPANY/MN — ADD
919,479 shares ($1.0M)
Price Targets
$3.95
+299.2% upside
Strong Buy
Current $0.9895
Low $2.00
Median $3.00
High $9.25
5 analysts
$2.00
$9.25
Analyst Ratings
3Strong Buy
7Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 8, 2026 | Ascendiant Capital | MAINTAIN | Buy → Buy |
| May 15, 2026 | Maxim Group | MAINTAIN | Buy → Buy |
| May 15, 2026 | BTIG | REITERATE | Buy → Buy |
| Apr 9, 2026 | Ascendiant Capital | MAINTAIN | Buy → Buy |
| Mar 30, 2026 | BTIG | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.06 ▲ +8.3% | $-0.07 — $-0.04 | 45% YoY | 4 |
| Next Q | $-0.05 ▲ +7.4% | $-0.06 — $-0.04 | 48% YoY | 4 |
| Current FY | $-0.24 ▼ -2.9% | $-0.27 — $-0.20 | 45% YoY | 3 |
| Next FY | $-0.17 ▲ +5.6% | $-0.19 — $-0.15 | 28% YoY | 4 |
Latest Reports
BEARISH
8-K
5/10
Lucid Diagnostics reported Q1 2026 revenue of $1.3M (up 52% YoY from $0.8M) and a GAAP net loss of $0.17/share, which is
May 14, 2026
NEUTRAL
8-K
5/10
Lucid Diagnostics Inc. (LUCD) closed an underwritten public offering of 18 million shares at $1.00 per share, raising $1
Apr 24, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $5.4M | DOUBLED |
| WELLS FARGO & COMPANY/MN | $1.0M | ADD |
| RENAISSANCE TECHNOLOGIES LLC | $900.9K | DOUBLED |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $245.2K | ADD |
| MORGAN STANLEY | $111.8K | NEAR_EXIT |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 20, 2026 | Matheis Dennis | BUY | $245.3K |
| Feb 20, 2026 | Matheis Dennis | A | $0.00 |
| Feb 20, 2026 | White Debra | A | $0.00 |
| Feb 20, 2026 | Sparks Ronald | A | $0.00 |
| Feb 20, 2026 | Aklog Lishan | A | $0.00 |
7 institutional holders with $7.8M total value (7,143,406 shares) as of 2025-Q4. Top holders: VANGUARD, WELLS, RENAISSANCE. Net buying activity: 5 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 4,968,608 | $5.4M | 69.6% | DOUBLED +364.3% |
| 2 | WELLS FARGO & COMPANY/MN | 919,479 | $1.0M | 12.9% | ADD +28.7% |
| 3 | RENAISSANCE TECHNOLOGIES LLC | 826,527 | $900.9K | 11.6% | DOUBLED +181.5% |
| 4 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 224,921 | $245.2K | 3.1% | ADD +28.6% |
| 5 | MORGAN STANLEY | 102,598 | $111.8K | 1.4% | NEAR_EXIT -79.1% |
| 6 | BANK OF AMERICA CORP /DE/ | 70,315 | $76.6K | 1.0% | ADD +72.9% |
| 7 | FMR LLC | 30,958 | $33.7K | 0.4% | DOUBLED +10117.2% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| WELLS FARGO & COMPANY/MN | ADD | 714,313 | 919,479 | +28.7% | $1.0M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 293,633 | 826,527 | +181.5% | $900.9K | 2025-Q4 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ADD | 174,868 | 224,921 | +28.6% | $245.2K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 40,663 | 70,315 | +72.9% | $76.6K | 2025-Q4 |
| FMR LLC | DOUBLED | 303 | 30,958 | +10117.2% | $33.7K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 226,860 | 714,313 | +214.9% | $721.5K | 2025-Q3 |
| UBS Group AG | DOUBLED | 66,785 | 145,244 | +117.5% | $146.7K | 2025-Q3 |
| MORGAN STANLEY | NEAR_EXIT | 466,630 | 97,699 | -79.1% | $98.7K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | ADD | 28,746 | 40,663 | +41.5% | $41.1K | 2025-Q3 |
| FMR LLC | TRIM | 1,159 | 303 | -73.9% | $306.00 | 2025-Q3 |
| VANGUARD GROUP INC | DOUBLED | 888,874 | 4,127,278 | +364.3% | $4.7M | 2025-Q2 |
| MORGAN STANLEY | DOUBLED | 111,590 | 466,630 | +318.2% | $536.6K | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 459,065 | 243,279 | -47.0% | $279.8K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | DOUBLED | 2,150 | 226,860 | +10451.6% | $260.9K | 2025-Q2 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 174,868 | — | $201.1K | 2025-Q2 |
| UBS Group AG | DOUBLED | 5,850 | 66,785 | +1041.6% | $76.8K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | TRIM | 42,897 | 28,746 | -33.0% | $33.1K | 2025-Q2 |
| FMR LLC | DOUBLED | 555 | 1,159 | +108.8% | $1.3K | 2025-Q2 |
| VANGUARD GROUP INC | ADD | 560,915 | 888,874 | +58.5% | $1.3M | 2025-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 459,065 | — | $684.0K | 2025-Q1 |
| MORGAN STANLEY | DOUBLED | 54,594 | 111,590 | +104.4% | $166.3K | 2025-Q1 |
| CITADEL ADVISORS LLC | NEW | — | 119,887 | — | $98.2K | 2024-Q4 |
| MORGAN STANLEY | DOUBLED | 394 | 54,594 | +13756.3% | $44.7K | 2024-Q4 |
| MORGAN STANLEY | TRIM | 954 | 394 | -58.7% | $321.00 | 2024-Q3 |
11 unique insiders with 1 transactions. Net insider value: $245.3K ($245.3K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 20, 2026 | Matheis Dennis | Director | BUY | 245,000 | $1.00 | $245.3K |
| Feb 20, 2026 | Matheis Dennis | Director | A | 123,000 | $0.00 | $0.00 |
| Feb 20, 2026 | White Debra | Director | A | 123,000 | $0.00 | $0.00 |
| Feb 20, 2026 | Sparks Ronald M | Director | A | 123,000 | $0.00 | $0.00 |
| Feb 20, 2026 | Aklog Lishan | Chief Executive Officer | A | 2,170,000 | $0.00 | $0.00 |
| Feb 20, 2026 | MCGRATH DENNIS M | Chief Financial Officer | A | 470,000 | $0.00 | $0.00 |
| Feb 20, 2026 | O'Neil Shaun | President and COO | A | 620,000 | $0.00 | $0.00 |
| Feb 20, 2026 | Cox James L | Director | A | 123,000 | $0.00 | $0.00 |
| Feb 20, 2026 | SOKOLOV JACQUE J | Director | A | 123,000 | $0.00 | $0.00 |
| Feb 20, 2026 | PALUMBO JOHN R | Director | A | 123,000 | $0.00 | $0.00 |
| Feb 20, 2026 | Lapidus Stanley | Director | A | 123,000 | $0.00 | $0.00 |
| Feb 20, 2026 | Gordon Michael Adam | General Counsel and Secretary | A | 300,000 | $0.00 | $0.00 |
3 SEC filing reports analyzed. Sentiment: 0 bullish, 1 bearish, 0 mixed, 2 neutral. Avg impact: 5.0/10.
BEARISH
8-K
5/10
Lucid Diagnostics reported Q1 2026 revenue of $1.3M (up 52% YoY from $0.8M) and a GAAP net loss of $
May 14, 2026
NEUTRAL
8-K
5/10
Lucid Diagnostics Inc. (LUCD) closed an underwritten public offering of 18 million shares at $1.00 p
Apr 24, 2026
NEUTRAL
8-K
5/10
Lucid Diagnostics is conducting an underwritten public offering of 18 million shares of common stock
Apr 23, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (91% buy). Based on 11 analysts: 3 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$3.95 mean target
+299.2% upside
Strong Buy (1.40)
$2.00 Low
$9.25 High
| Metric | Value |
|---|---|
| Current Price | $0.9895 |
| Target Low | $2.00 |
| Target Mean | $3.95 |
| Target Median | $3.00 |
| Target High | $9.25 |
| # Analysts | 5 |
| Recommendation | Strong Buy (1.40) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.06 | $-0.07 | $-0.04 | 45.0% | +8.3% | 1↑ 0↓ | $0.0B | 23.2% | 4 |
| Next Q 2026-09-30 |
$-0.05 | $-0.06 | $-0.04 | 47.5% | +7.4% | 1↑ 0↓ | $0.0B | 59.6% | 4 |
| Current FY 2026-12-31 |
$-0.24 | $-0.27 | $-0.20 | 45.0% | -2.9% | 0↑ 1↓ | $0.0B | 56.7% | 3 |
| Next FY 2027-12-31 |
$-0.17 | $-0.19 | $-0.15 | 28.2% | +5.6% | 2↑ 1↓ | $0.0B | 172.7% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.055 | |
| 7d ago | $-0.058 | +0.003 |
| 30d ago | $-0.060 | +0.005 |
| 60d ago | $-0.063 | +0.008 |
| 90d ago | $-0.075 | +0.020 |
4 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 8, 2026 | Ascendiant Capital | MAINTAIN | Buy | Buy |
| May 15, 2026 | Maxim Group | MAINTAIN | Buy | Buy |
| May 15, 2026 | BTIG | REITERATE | Buy | Buy |
| Apr 9, 2026 | Ascendiant Capital | MAINTAIN | Buy | Buy |
| Mar 30, 2026 | BTIG | REITERATE | Buy | Buy |
| Mar 26, 2026 | Needham | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% | |
| May 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% | |
| Apr 1, 2026 | 3 | 7 | 1 | 0 | 0 | 91% | |
| Mar 1, 2026 | 3 | 8 | 1 | 0 | 0 | 92% | |
| Feb 1, 2026 | 3 | 8 | 1 | 0 | 0 | 92% | |
| Jan 1, 2026 | 3 | 8 | 1 | 0 | 0 | 92% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 9, 2026
short_volume
Short Volume: LUCD — 59.8% short (0.3M / 0.5M)
Short: 321,716 | Exempt: 222 | TRF Vol: 538,080 | Short Ratio: 59.8% | Off-exchange volume (dark pool + OTC)
Jun 5, 2026
short_volume
Short Volume: LUCD — 72.2% short (0.4M / 0.6M)
Short: 398,588 | Exempt: 1,786 | TRF Vol: 552,100 | Short Ratio: 72.2% | Off-exchange volume (dark pool + OTC)
May 20, 2026
short_volume
Short Volume: LUCD — 59.3% short (0.5M / 0.9M)
Short: 544,949 | Exempt: 1,115 | TRF Vol: 918,772 | Short Ratio: 59.3% | Off-exchange volume (dark pool + OTC)
May 18, 2026
short_volume
Short Volume: LUCD — 69.3% short (0.4M / 0.6M)
Short: 423,710 | Exempt: 0 | TRF Vol: 611,213 | Short Ratio: 69.3% | Off-exchange volume (dark pool + OTC)
May 15, 2026
short_volume
Short Volume: LUCD — 85.3% short (0.6M / 0.7M)
Short: 609,089 | Exempt: 51 | TRF Vol: 714,428 | Short Ratio: 85.3% | Off-exchange volume (dark pool + OTC)
May 14, 2026
earnings_calendar
LUCD Q1 2026 Earnings Before Market Open — 2026-05-14
May 14, 2026
short_volume
Short Volume: LUCD — 72.1% short (0.7M / 1.0M)
Short: 728,271 | Exempt: 1,073 | TRF Vol: 1,010,002 | Short Ratio: 72.1% | Off-exchange volume (dark pool + OTC)
May 7, 2026
short_volume
Short Volume: LUCD — 58.6% short (0.3M / 0.5M)
Short: 297,958 | Exempt: 923 | TRF Vol: 508,235 | Short Ratio: 58.6% | Off-exchange volume (dark pool + OTC)
Apr 24, 2026
short_volume
Short Volume: LUCD — 59.2% short (0.3M / 0.6M)
Short: 342,622 | Exempt: 26,489 | TRF Vol: 578,317 | Short Ratio: 59.2% | Off-exchange volume (dark pool + OTC)
Apr 14, 2026
short_volume
Short Volume: LUCD — 60.5% short (0.5M / 0.8M)
Short: 507,091 | Exempt: 5,649 | TRF Vol: 838,505 | Short Ratio: 60.5% | Off-exchange volume (dark pool + OTC)
Mar 23, 2026
earnings_calendar
LUCD Q4 2025 Earnings After Market Close — 2026-03-23